# Saxagliptin and Cardiac Structure and Function

> **NCT02481479** · PHASE4 · COMPLETED · sponsor: **Unity Health Toronto** · enrollment: 18 (actual)

## Conditions studied

- Diabetes Mellitus, Non-Insulin-Dependent
- Heart Failure

## Interventions

- **DRUG:** Saxagliptin
- **DRUG:** Saxagliptin
- **DRUG:** saxagliptin

## Key facts

- **NCT ID:** NCT02481479
- **Lead sponsor:** Unity Health Toronto
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-06
- **Primary completion:** 2018-08
- **Final completion:** 2018-08
- **Target enrollment:** 18 (ACTUAL)
- **Last updated:** 2020-03-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02481479

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02481479, "Saxagliptin and Cardiac Structure and Function". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT02481479. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*